From Nasdaq: 2025-05-08 06:30:00

Hims & Hers CEO Andrew Dudum is focused on disrupting the healthcare industry by not incorporating insurance into his platform, as seen on the NASDAQ stock market under the ticker symbol HIMS. Potential growth stock if demand aggregation plans succeed. Stock prices as of May 6, 2025, with a video published on May 7, 2025.

Consider investing $1,000 in Hims & Hers Health. Motley Fool’s Stock Advisor team identified the 10 best stocks to buy, excluding Hims & Hers Health. Top 10 stocks have historically produced significant returns. Stock Advisor’s average return is 893%, outperforming the S&P 500 at 162%. Latest top 10 list available with Stock Advisor membership.

Former Whole Foods CEO John Mackey and Randi Zuckerberg sit on Motley Fool’s board. Analyst Travis Hoium holds positions in Hims & Hers Health, among others. Motley Fool recommends Amazon, Meta Platforms, Netflix, and others. Affiliate links may result in compensation. Consider subscribing through their link to support them.



Read more at Nasdaq: Hims & Hers Has a Superpower in Healthcare